Skip to content
CNS Clinical Research

Minneapolis, Minnesota

CNS clinical trials in Minneapolis, MN

48 CNS studies are recruiting participants at sites in Minneapolis as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Minneapolis at a glance

  • 48 studies are recruiting at a site in Minneapolis.
  • By phase: Early Phase 1 (3), Phase 1 (2), Phase 1/2 (1), Phase 2 (1), Phase 3 (7), Phase 4 (1), No phase (23), Observational (10). Studies of devices and behavioral approaches have no phase.
  • By sponsor: university, hospital or other (33), industry (11), government (4).
  • By research area: Parkinson's Disease (19), Depression (13), Epilepsy (5), Migraine (4), Schizophrenia (4), ADHD (2), Bipolar Disorder (1).
  • Most recent update to one of these records: November 16, 2026.

Depression studies recruiting in Minneapolis

Basic details from each study's public record (the 30 most recently updated of 48). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    LivaNova
    Study site
    University of Minnesota
    Registry record
    NCT03887715 · updated
  2. Study of ALTO-300 in MDD

    • Phase 2
    • Ages 18 to 70
    • All sexes
    Sponsor
    Alto Neuroscience
    Registry record
    NCT05922878 · updated
  3. Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

    • No phase
    • Ages 22 to 70
    • All sexes
    Sponsor
    Abbott Medical Devices
    Study site
    University of Minnesota Medical Center Fairview
    Registry record
    NCT06423430 · updated
  4. Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental Illness

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    VA Office of Research and Development
    Study site
    Minneapolis VA Health Care System, Minneapolis, MN
    Registry record
    NCT05491538 · updated
  5. Effect of Vagal Nerve Stimulation on Gastric Motor Functions

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    University of Minnesota
    Registry record
    NCT06038929 · updated
  6. RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Boston University
    Study site
    VA Minneapolis Healthcare System
    Registry record
    NCT06906302 · updated
  7. Transdiagnostic Cognitive Biomarkers

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Minnesota
    Study site
    University of Minnesota
    Registry record
    NCT04864080 · updated
  8. PCS in Severe Treatment Resistant Depression

    • No phase
    • Ages 22 to 70
    • All sexes
    Sponsor
    University of Minnesota
    Study site
    University of Minnesota
    Registry record
    NCT04124341 · updated
  9. Cognitive Strategies in Early Psychosis 2

    • Phase 3
    • Ages 18 to 35
    • All sexes
    Sponsor
    University of Minnesota
    Study site
    University of Minnesota
    Registry record
    NCT07263022 · updated
  10. Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior

    • No phase
    • Ages 13 to 21
    • All sexes
    Sponsor
    University of Minnesota
    Study site
    University of Minnesota
    Registry record
    NCT05652153 · updated
  11. Cognitive and Affective Processes Online

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Minnesota
    Study site
    University of Minnesota
    Registry record
    NCT05736471 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Minneapolis, MN on ClinicalTrials.gov.

Schizophrenia studies recruiting in Minneapolis

  1. Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1

    • No phase
    • Ages 18 to 59
    • All sexes
    Sponsor
    Washington University School of Medicine
    Study site
    University of Minnesota
    Registry record
    NCT07853807 · updated
  2. Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 3

    • No phase
    • Ages 18 to 59
    • All sexes
    Sponsor
    Washington University School of Medicine
    Study site
    University of Minnesota
    Registry record
    NCT07900893 · updated
  3. State Representation in Early Psychosis 2

    • Observational
    • Ages 15 to 45
    • All sexes
    Sponsor
    University of Minnesota
    Study sites
    University of Minnesota Ambulatory Research Center · University of Minnesota Department of Psychology
    Registry record
    NCT07834203 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Minneapolis, MN on ClinicalTrials.gov.

ADHD studies recruiting in Minneapolis

  1. The Myelin Disorders Biorepository Project

    • Observational
    • All ages
    • All sexes
    Sponsor
    Children's Hospital of Philadelphia
    Study site
    University of Minnesota
    Registry record
    NCT03047369 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Minneapolis, MN on ClinicalTrials.gov.

Parkinson's disease studies recruiting in Minneapolis

  1. DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    AstraZeneca
    Registry record
    NCT06989112 · updated
  2. A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Minnesota Oncology Hematology, PA ( Site 8003)
    Registry record
    NCT06952504 · updated
  3. Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Allina Health Cancer Institute - Abbott Northwestern Hospital ( Site 0115)
    Registry record
    NCT06170788 · updated
  4. Effects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease

    • No phase
    • Ages 21 to 76
    • All sexes
    Sponsor
    University of Minnesota
    Study site
    Movement Disorders Laboratory
    Registry record
    NCT07226284 · updated
  5. Kinematic and Neural Dynamics of Postural Instability in Parkinson's Disease

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    VA Office of Research and Development
    Study site
    Minneapolis VA Health Care System, Minneapolis, MN
    Registry record
    NCT06405334 · updated
  6. Bayesian Optimization of DBS for Gait

    • Early Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Minnesota
    Study site
    University of Minnesota
    Registry record
    NCT07835308 · updated
  7. Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

    • Phase 4
    • Ages 40 and older
    • All sexes
    Sponsor
    VA Office of Research and Development
    Study site
    Minneapolis VA Health Care System, Minneapolis, MN
    Registry record
    NCT04373317 · updated
  8. Pathways Mediating Impaired Postural Control in Parkinson's Disease

    • Observational
    • Ages 45 to 80
    • All sexes
    Sponsor
    University of Minnesota
    Study site
    University of Minnesota
    Registry record
    NCT06464029 · updated
  9. Imaging Core Aim 2, and Udall Project 2 Aim 2

    • No phase
    • Ages 21 and older
    • All sexes
    Sponsor
    University of Minnesota
    Study site
    University of Minnesota
    Registry record
    NCT06998303 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Minneapolis, MN on ClinicalTrials.gov.

Epilepsy studies recruiting in Minneapolis

  1. Diagnosing Epilepsy To EffeCT Change

    • No phase
    • Ages 18 to 75
    • All sexes
    Sponsor
    Epiminder America, Inc.
    Study site
    University of Minnesota
    Registry record
    NCT07110337 · updated
  2. Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

    • Observational
    • Ages 18 to 75
    • All sexes
    Sponsor
    Epiminder America, Inc.
    Study site
    University of Minnesota
    Registry record
    NCT07110454 · updated
  3. Optimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy

    • Early Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Minnesota
    Study site
    University of Minnesota
    Registry record
    NCT05493722 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Minneapolis, MN on ClinicalTrials.gov.

Migraine studies recruiting in Minneapolis

  1. A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Study site
    Clinical Research Institute
    Registry record
    NCT07645924 · updated
  2. A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Study site
    Clinical Research Institute
    Registry record
    NCT07674654 · updated
  3. A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

    • Phase 1
    • Ages 6 to 11
    • All sexes
    Sponsor
    Pfizer
    Study site
    Clinical Research Institute
    Registry record
    NCT06995729 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Minneapolis, MN on ClinicalTrials.gov.

Ask about studies near Minneapolis

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Minnesota

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call